Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Narumi Hara"'
Autor:
Mahoko Furujo, Motoharu Ochi, Yousuke Higuchi, Takahiro Namba, Yuki Ebuchi, Hiroki Tsuchiya, Shoko Fujinaga, Naoko Urata, Toshihide Kubo, Michiko Kishi, Narumi Hara
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 33:1417-1423
Background The relationship between growth hormone (GH)-replacement therapy and the thyroid axis in GH-deficient (GHD) children remains controversial. Furthermore, there have been few reports regarding non-GHD children. We aimed to determine the effe
Autor:
Narumi Harada, Junji Yatsuda, Ryoma Kurahashi, Yumi Fukushima, Takuya Segawa, Takanobu Motoshima, Yoji Murakami, Takahiro Yamaguchi, Yutaka Sugiyama, Tomomi Kamba
Publikováno v:
IJU Case Reports, Vol 5, Iss 4, Pp 281-285 (2022)
Introduction Subcapsular renal hematoma after ureterorenoscopy using a holmium yttrium‐aluminum‐garnet laser is a rare complication. We experienced a case of subcapsular hematoma after ureterorenoscopy. Case presentation The patient was a 56‐ye
Externí odkaz:
https://doaj.org/article/9124b2782144448591db10b9b6eee099
Autor:
Miku Sato, Narumi Harada-Shoji, Takafumi Toyohara, Tomoyoshi Soga, Masatoshi Itoh, Minoru Miyashita, Hiroshi Tada, Masakazu Amari, Naohiko Anzai, Shozo Furumoto, Takaaki Abe, Takashi Suzuki, Takanori Ishida, Hironobu Sasano
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract 18F-FDG PET/CT has been used as an indicator of chemotherapy effects, but cancer cells can remain even when no FDG uptake is detected, indicating the importance of exploring other metabolomic pathways. Therefore, we explored the amino acid m
Externí odkaz:
https://doaj.org/article/d8250aa6fd4543e7bd61b2f89b38002b
Autor:
Haruhiko Shindo, Narumi Harada-Shoji, Akiko Ebata, Miku Sato, Tomoyoshi Soga, Minoru Miyashita, Hiroshi Tada, Masaaki Kawai, Shinkichi Kosaka, Koji Onuki, Shin Usami, Shozo Furumoto, Shinichi Hayashi, Takaaki Abe, Takashi Suzuki, Takanori Ishida, Hironobu Sasano
Publikováno v:
Cancers, Vol 13, Iss 17, p 4375 (2021)
The PI3K/Akt/mTOR pathway has been well known to interact with the estrogen receptor (ER)-pathway and to be also frequently upregulated in aromatase inhibitor (AI)-resistant breast cancer patients. Intracellular levels of free amino acids, especially
Externí odkaz:
https://doaj.org/article/8b9fec99af9a4db78708c797983d2cfb
Autor:
Zhaorong Guo, Hiroshi Tada, Narufumi Kitamura, Yoh Hamada, Minoru Miyashita, Narumi Harada-Shoji, Akiko Sato, Yohei Hamanaka, Kouki Tsuboi, Nobuhisa Harada, Mayumi Takano-Kasuya, Hisatake Okada, Yasushi Nakano, Noriaki Ohuchi, Shin-ichi Hayashi, Takanori Ishida, Kohsuke Gonda
Publikováno v:
Cancers, Vol 11, Iss 4, p 526 (2019)
In addition to genomic signaling, Estrogen receptor alpha (ERα) is associated with cell proliferation and survival through extranuclear signaling contributing to endocrine therapy (ET) resistance. However, the relationship between extranuclear ERα
Externí odkaz:
https://doaj.org/article/59d068b234044a02a1694b269ef69861